Clinical trial
Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump…
NCT00251732 · University of Arizona, Other · Completed
Key facts
| NCT number | NCT00251732 |
|---|---|
| Title | Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) |
| Official title | Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI. |
| Lead sponsor | University of Arizona, Other |
| Collaborators | Southern Arizona VA Health Care System U.S. Fed Janssen Pharmaceutica N.V., Belgium Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | Standard dose (once daily) PPI plus low-dose antidepressant, Double dose PPI plus evening placebo, Rabeprazole, placebo |
| Enrollment | 150 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Nov 10, 2005 |
| Last update posted | Aug 19, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: